3RIL: The Acid Beta-Glucosidase Active Site Exhibits Plasticity In 3,4,5,6-Tetrahydroxyazepane-Based Inhibitors: Implications Pharmacological Chaperone Design For Gaucher Disease
reference: Binding of 3,4,5,6-tetrahydroxyazepanes to the acid-beta-glucosidase active site: implications for pharmacological chaperone design for Gaucher disease., Orwig SD, Tan YL, Grimster NP, Yu Z, Powers ET, Kelly JW, Lieberman RL, Biochemistry. 2011 Dec 13;50(49):10647-57. Epub 2011 Nov 14. PMID: 22047104

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).